Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Levy

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|June 23, 2026
Paediatric Healthcare Utilisation Trends From the Pre-Pandemic Period Through Two Years Post-COVID-19: Evidence From a Nationwide Big-Data AnalysisEinat Shmueli, Elite Gutman, Joseph Levy, et al.
International Journal of Cancer|January 6, 2006
Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemiaHagar Sharabani, Eugene Izumchenko, Qing Wang, et al.
Journal of Orthopaedic Trauma|October 10, 2019
Valuing the Recovery Priorities of Orthopaedic Trauma Patients After Injury: Evidence From a Discrete Choice Experiment Within 6 Weeks of InjuryNathan N OʼHara, Alexandra Mulliken, Katherine Joseph, et al.
Plos One|August 27, 2015
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular HypoxiaNathan A Koonce, Joseph Levy, Matthew E Hardee, et al.
European Journal of Nutrition|February 26, 2014
Exploring the benefits and challenges of establishing a DRI-like process for bioactivesJoanne R Lupton, Stephanie A Atkinson, Namsoo Chang, et al.
Nature Communications|September 8, 2020
Developing a COVID-19 mortality risk prediction model when individual-level data are not availableNoam Barda, Dan Riesel, Amichay Akriv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Journal of Autism and Developmental Disorders|October 24, 2018
Development of a Brief Parent-Report Screen for Common Gastrointestinal Disorders in Autism Spectrum DisorderKara G Margolis, Timothy M Buie, J Blake Turner, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Acta Paediatrica (Oslo, Norway : 1992)|June 23, 2026
Paediatric Healthcare Utilisation Trends From the Pre-Pandemic Period Through Two Years Post-COVID-19: Evidence From a Nationwide Big-Data AnalysisEinat Shmueli, Elite Gutman, Joseph Levy, et al.
International Journal of Cancer|January 6, 2006
Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemiaHagar Sharabani, Eugene Izumchenko, Qing Wang, et al.
Journal of Orthopaedic Trauma|October 10, 2019
Valuing the Recovery Priorities of Orthopaedic Trauma Patients After Injury: Evidence From a Discrete Choice Experiment Within 6 Weeks of InjuryNathan N OʼHara, Alexandra Mulliken, Katherine Joseph, et al.
Plos One|August 27, 2015
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular HypoxiaNathan A Koonce, Joseph Levy, Matthew E Hardee, et al.
European Journal of Nutrition|February 26, 2014
Exploring the benefits and challenges of establishing a DRI-like process for bioactivesJoanne R Lupton, Stephanie A Atkinson, Namsoo Chang, et al.
Nature Communications|September 8, 2020
Developing a COVID-19 mortality risk prediction model when individual-level data are not availableNoam Barda, Dan Riesel, Amichay Akriv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 13, 2004
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipientsIfeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison, et al.
Journal of Autism and Developmental Disorders|October 24, 2018
Development of a Brief Parent-Report Screen for Common Gastrointestinal Disorders in Autism Spectrum DisorderKara G Margolis, Timothy M Buie, J Blake Turner, et al.
Pageof 8